Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children

Virology

Volumn 250, Issue 2, 1998, Pages 316-324

  Buseyne, Florence ^a   Chaix, Marie Laure ^b   Fleury, Béatrice ^a   Manigard, Olivier ^b   Burgard, Marianne ^b   Blanche, Stéphane ^b   Rouzioux, Christine ^b   Rivière, Yves ^a  

^a INSTITUT PASTEUR   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; DNA;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINIA VIRUS; VIRUS INFECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; VACCINIA; VACCINIA VIRUS;

EID: 18344418549     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9373     Document Type: Article

References (32)

1. Betts M. R., Krowka J., Santamaria C., Balsamo K., Gao F., Mulundu G., Luo C, N'Gandu N., Sheppard H., Hahn B. H., Allen S., Frelinger J. A. Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocytes responses in HIV-infected Zambians. J. Virol. 71:1997;8908-8911.
2. +. J. Virol. 68:1994;6103-6110.
3. Buseyne F., Blanche S., Schmitt D., Griscelli C., Rivière Y. Detection of HIV-specific cell mediated cytotoxicity in the peripheral from infected children. J. Immunol. 150:1993;3569-3581.
4. Cao H., Kanki P., Sankalé J. L., Dieng-Sarr A., Mazzara G. P., Kalams S. A., Korber B., Mboup S., Walker B. D. Cytotoxic-T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development. J. Virol. 71:1997;8615-8623.
5. MMWR Morb. Mortal. Weekly Rep. 43:1994;1-10.
6. Delwart E. L., Shpaer F. G., McCutchan F. E., Louwagie J., Grez M., Rubsamen-Waigmann H., Mullins J. Genetic relationships determined by a heteroduplex mobility assay: analysis of HIV env genes. Science. 262:1993;1257-1261.
7. Dumitrescu O., Kalish M. L., Kliks S. C., Bandea C. I., Levy J. A. Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype. J. Infect. Dis. 169:1994;281-288.
8. Durali D., Morvan J., Letourneur F., Schmitt D., Guegan N., Dalod M., Saragosti S., Sicard D., Levy J. P., Gomard E. Cross-reactions between the cytotoxic T lymphocytes responses from HIV-infected African and European patients. J. Virol. 72:1998;3547-3553.
9. Ferrari G., Humphrey W., McElrath M. J., Excler J. L., Duliège A. M., Clements M. L., Corey L. C., Bolognesi D. P., Weinhold K. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocye reactivities in uninfected volunteers. Proc. Natl. Acad. Sci. USA. 94:1997;1396-1401.
10. Felsenstein, J. 1993, PHYLIP (phylogeny Interference Package) Version 3.5c, Berkeley University Herbarium, University of California.
11. Fu T. M., Friedman A., Ulmer J. B., Liu M. A., Donelly J. J. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J. Virol. 71:1997;2715-2721.
12. Greenough T. C., Brettler D. B., Somasundaran M., Panicali D. L., Sullivan J. L. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), viral load, and CD4+ T cell loss: evidence supporting a protective role for CTL in vivo. J. Infect. Dis. 176:1997;118-125.
13. Imanishi, T. Akaza, T. Kimura, A. Tokunaga, K. Gojobori, T. 1992, Allele and haplotype frequencies for HLA and complement loci in various ethnic groups, In, Proceedings of the Eleventh International Histocompatibility Workshop and Conference, 1065, 1156, Oxford University Press.
14. Janssens W., Buvé A., Nkengasong J. N. The puzzle of HIV-1 subtypes in Africa. AIDS. 11:1997;705-712.
15. Johnson R. P., Walker B. D. Cytotoxic T cells in human immunodeficiency virus infection: responses to structural proteins. Curr. Top. Microbiol. Immunol. 189:1994;35-63.
16. Klein M. R., Van Baalen C. A., Holwerda A. M., Kerkhof Garde S. R., Bende R. J., Keet I. P. M., Eeftinck-Schattenderk J.-K. M., Osterhaus A. D. M. E., Schuitmaker H., Mediema F. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1995;1365-1372.
17. Koup R. A., Safrit J. T., Cao Y., Andrew C. A., McLeod G., Borkowsky W., Frathing C., Ho D. D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:1994;4650-4655.
18. Krausa P., Brywka M. I., Savage D., Hui K. M., Bunce M., Ngai J. L., Teo D. L. T., Ong Y. W., Barouch D., Allsop C. E. M., Hill A. V. S., McMichael A. J., Bodmer A. J., Browning M. J. Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens. 45:1995;223-231.
19. Lamhamedi-Cherradi S., Culmann-Penciolelli B., Guy B., Ly T. D., Goujard C., Guillet J.-G., Gomard E. Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection. AIDS. 9:1995;421-426.
20. Luzuriaga K., Holmes D., Hereema A., Wong J., Panicali D. L., Sullivan J. L. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J. Immunol. 154:1995;433-443.
21. Luzuriaga K., Koup R. A., Pikora C. A., Bretter D. B., Sullivan J. L. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children. J. Pediatr. 119:1991;230-236.
22. Martins L. P., Lau L. L., Asano M. S., Ahmed R. DNA vaccination against persistent viral infection. J. Virol. 69:1995;2574-2582.
23. McAdam S., Kaleebu P., Krausa P., Goulder P., French N., Collin B., Blanchard T., Whitworth J., McMichael A., Gotch F. Cross-clade recognition by cytotoxic T lymphocytes in HIV-1 infection. AIDS. 12:1998;571-579.
24. McFarland E. J., Harding P. A., Luckey D., Conway B., Young R. K., Kuritzkes D. R. High frequency of gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection. J. Infect. Dis. 170:1994;766-774.
25. Myers G., Korber B., Foley B., Jeang K.-T., Mellors J. W., Wain-Hobson S. Human Retroviruses and AIDS. 1996;Los Alamos National LaboratoryTheoretical Biology and Biophysics Group, Los Alamos.
26. Ogg G. S., Jin X., Bonhoeffer S., Dunbar R., Nowak M. A., Monard S., Segal J. P., Cao Y., Rowland-Jones S., Cerundolo V., Hurley A., Markowitz M., Ho D. D., Nixon D. F., McMichael A. J. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma viral load of viral RNA. Science. 279:1998;2103-2106.
27. Rivière Y., Tanneau F., Regnault A., Lopez O., Sansonetti P., Guy B., Kieny M. P., Fournel J.-J., Montagnier L. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effectors cells mediate killing of targets expressing gag and env proteins. J. Virol. 63:1989;2270-2277.
28. Rivière Y., McChesney M. B., Porrot F., Tanneau-Salvadori F., Sansonetti P., Lopez O., Pialoux G., Feuillie V., Mollereau M., Chamaret S., Tekaia F., Montagnier L. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res. Hum. Retro. 11:1995;903-907.
29. Rivière Y., Robertson M., Buseyne F. Cytotoxic T lymphocytes in human immunodeficiency virus infection: regulator genes. Curr. Top. Microbiol. Immunol. 189:1994;65-74.
30. Simon F., Loussert-Ajaka I., Damond F., Saragosti S., Barin F., Brun-Vézinet F. HIV type 1 diversity in northern Paris, France. AIDS Res. Hum. Retro. 12:1996;1427-1433.
31. AIDS. 11:1997;UNAIDS17-UNAIDS36.
32. Yokoyama M., Zhang J., Whitton J. L. DNA immunization confers protection against lethal lymphocytic choriomenigitis virus infection. J. Virol. 69:1995;2684-2688.